Oramed Pharmaceuticals (ORMP) Treasury Shares (2015 - 2025)
Oramed Pharmaceuticals (ORMP) posted Treasury Shares of $4.4 million for Q4 2025, up 70.43% on a QoQ basis from $2.6 million in Q4 2024, and up 70.43% year-over-year from $2.6 million in Q4 2024.
Oramed Pharmaceuticals (ORMP) Treasury Shares (2015 - 2025) Analysis & Trends
Oramed Pharmaceuticals' Treasury Shares history runs 11 years deep, the most recent figure standing at $4.4 million for Q4 2025.
- Quarterly Treasury Shares rose 70.43% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (up 70.43% YoY) and the FY2025 annual result came in at $4.4 million, up 70.43% from the prior year.
- Treasury Shares was $4.4 million for Q4 2025 at Oramed Pharmaceuticals, up from $2.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at $7.5 million in Q2 2022 and bottomed at $539452.0 in Q3 2024.
- A 5-year average of $2.8 million and a median of $1.8 million in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares surged 459.6% — and 2023, when it rose 17.47%.
- Oramed Pharmaceuticals' Treasury Shares stood at $921302.0 in 2021, then soared by 69.5% to $1.6 million in 2022, then climbed by 17.47% to $1.8 million in 2023, then jumped by 40.22% to $2.6 million in 2024, then surged by 70.43% to $4.4 million in 2025.
- Business Quant data shows ORMP's Treasury Shares at $4.4 million in Q4 2025, $2.6 million in Q4 2024, and $539452.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 539,452.00 |
| Sep 30, 2024 | 539,452.00 |
| Dec 31, 2023 | 1.83 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Jun 30, 2022 | 7.50 Mn |
| Jun 30, 2022 | 7.50 Mn |
| Aug 31, 2021 | 921,302.00 |
| Aug 31, 2021 | 921,302.00 |
| Aug 31, 2020 | 164,636.00 |
| Aug 31, 2020 | 164,636.00 |
| Aug 31, 2019 | 164,636.00 |
| Aug 31, 2019 | 164,636.00 |
| Aug 31, 2018 | 165,796.00 |
| Aug 31, 2018 | 165,796.00 |